…
The fifth NGN-PET project meeting was held on July 2nd & 3rd, hosted by the Natural and Medical Sciences Institute, at the University of Tübingen. During the meeting the team shared the results obtained so far in the different work packages, and agreed on next steps for acomplishing with the overall objectives of the project. Several partial objectives have been…
The fourth face-to-face meeting of the NGN-PET project took place on November 22nd and 23rd, at the Life & Brain facilities in Bonn (Germany). A new opportunity to meet all together for sharing results, taking decisions and planning the work for the coming months. Twenty-two scientists representing all the partners joined the meeting. Good progress has been achieved in the…
New NGN-PET poster presented at the IMI 10th Anniversary Scientific Symposium,
Brussels, October 22nd-23rd, 2018.
NGN-PET Project held its 3rd face-to-face meeting in Bresso, at AXXAM’s headquarters. Representatives of all the partners and the IMI Officer, Colm Carroll, joint the meeting. Like in previous editions, the meeting was a excellent opportunity to share and discuss the results we had obtained so far, and to agree on next steps. The NGN-PET project has accomplished with the…
The second NGN-PET project face-to-face meeting was held in London on November 6th & 7th, hosted by King’s College. Thirty scientists from the research centers and the IMI officer Colm Carroll joined the meeting. The different workpackages gave an update on the results obtained so far. The progress of the project is in line with the planned activities.
Axxam is proud to announce its participation to the NGN-PET project, that will provide a translational platform of rodent and human neuropathic pain models for the identification and validation of new targets and biomarkers, and suitable for the discovery of new drugs. The project investigates neuron-glia interactions for the identification of novel therapeutic approaches, and for the development of innovative…
Professor Stephen McMahon and Dr Franziska Denk from the Wolfson Centre for Age-Related Diseases have been awarded EUR 450,000, as part of a new European research consortium funded by the Innovative Medicine Initiative (IMI2). The consortium, named NGN-PET, brings together partners from industry and academia and has a total budget of 3.3 million Euros over three years. It aims to…
The NGN-PET consortium aims to explore neuron-glial interactions in subtypes of neuropathic pain which are induced by chemotherapy or trauma, and to develop human-predictive test systems that can be implemented in the drug discovery process. These cellular systems will use preclinical tissues and human iPSC-derived neuron-glia co-culturesin novel high-throughput screening platfor to identify novel more efficacious treatments for neuropathic pain…
NGN-PET is a project launched in the framework of the Innovative Medicine Initiative (IMI), the largest public-private partnership (PPP) for health research worldwide co-funded by the EU and the European pharmaceutical industry. ESTEVE, along with five other partners, is part of this project for the development of novel, more efficacious treatments for chronic pain of neuropathic origin Neuropathic pain affects…
